Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

A review of the clinical utility of serum S100B protein levels in the assessment of traumatic brain injury.

Thelin EP, Nelson DW, Bellander BM.

Acta Neurochir (Wien). 2017 Feb;159(2):209-225. doi: 10.1007/s00701-016-3046-3. Epub 2016 Dec 12. Review.

2.

Utility of neuron-specific enolase in traumatic brain injury; relations to S100B levels, outcome, and extracranial injury severity.

Thelin EP, Jeppsson E, Frostell A, Svensson M, Mondello S, Bellander BM, Nelson DW.

Crit Care. 2016 Sep 8;20:285. doi: 10.1186/s13054-016-1450-y.

3.

Role of the S100B serum biomarker in the treatment of children suffering from mild traumatic brain injury.

Filippidis AS, Papadopoulos DC, Kapsalaki EZ, Fountas KN.

Neurosurg Focus. 2010 Nov;29(5):E2. doi: 10.3171/2010.8.FOCUS10185. Review.

PMID:
21039136
4.

Predicting outcome after severe traumatic brain injury using the serum S100B biomarker: results using a single (24h) time-point.

Rainey T, Lesko M, Sacho R, Lecky F, Childs C.

Resuscitation. 2009 Mar;80(3):341-5. doi: 10.1016/j.resuscitation.2008.11.021. Epub 2009 Jan 15.

PMID:
19150161
5.

GFAP versus S100B in serum after traumatic brain injury: relationship to brain damage and outcome.

Pelinka LE, Kroepfl A, Leixnering M, Buchinger W, Raabe A, Redl H.

J Neurotrauma. 2004 Nov;21(11):1553-61.

PMID:
15684648
6.

Kinetic modelling of serum S100b after traumatic brain injury.

Ercole A, Thelin EP, Holst A, Bellander BM, Nelson DW.

BMC Neurol. 2016 Jun 17;16:93. doi: 10.1186/s12883-016-0614-3.

7.

Role of serum S100B as a predictive marker of fatal outcome following isolated severe head injury or multitrauma in males.

da Rocha AB, Schneider RF, de Freitas GR, André C, Grivicich I, Zanoni C, Fossá A, Gehrke JT, Pereira Jotz G, Kaufmann M, Simon D, Regner A.

Clin Chem Lab Med. 2006;44(10):1234-42.

PMID:
17032136
8.

Functional resting-state fMRI connectivity correlates with serum levels of the S100B protein in the acute phase of traumatic brain injury.

Thompson WH, Thelin EP, Lilja A, Bellander BM, Fransson P.

Neuroimage Clin. 2016 May 9;12:1004-1012. eCollection 2016.

9.

Early CSF and Serum S100B Concentrations for Outcome Prediction in Traumatic Brain Injury and Subarachnoid Hemorrhage.

Kellermann I, Kleindienst A, Hore N, Buchfelder M, Brandner S.

Clin Neurol Neurosurg. 2016 Jun;145:79-83. doi: 10.1016/j.clineuro.2016.04.005. Epub 2016 Apr 8.

PMID:
27101088
10.

Resuscitation with hypertonic saline-dextran reduces serum biomarker levels and correlates with outcome in severe traumatic brain injury patients.

Baker AJ, Rhind SG, Morrison LJ, Black S, Crnko NT, Shek PN, Rizoli SB.

J Neurotrauma. 2009 Aug;26(8):1227-40. doi: 10.1089/neu.2008.0868.

PMID:
19637968
11.

Serum Concentrations of Ubiquitin C-Terminal Hydrolase-L1 and Glial Fibrillary Acidic Protein after Pediatric Traumatic Brain Injury.

Mondello S, Kobeissy F, Vestri A, Hayes RL, Kochanek PM, Berger RP.

Sci Rep. 2016 Jun 20;6:28203. doi: 10.1038/srep28203.

12.

Ability of S100B to predict severity and cranial CT results in children with TBI.

Babcock L, Byczkowski T, Mookerjee S, Bazarian JJ.

Brain Inj. 2012;26(11):1372-80. doi: 10.3109/02699052.2012.694565. Epub 2012 Jun 22.

PMID:
22725661
13.

Model predicting survival/exitus after traumatic brain injury: biomarker S100B 24h.

Gonzćlez-Mao MC, Repáraz-Andrade A, Del Campo-Pérez V, Alvarez-García E, Vara-Perez C, Andrade-Olivié MA.

Clin Lab. 2011;57(7-8):587-97.

PMID:
21888023
14.

S100B is not a reliable prognostic index in paediatric TBI.

Piazza O, Storti MP, Cotena S, Stoppa F, Perrotta D, Esposito G, Pirozzi N, Tufano R.

Pediatr Neurosurg. 2007;43(4):258-64.

PMID:
17627141
15.

Post-mortem biochemistry of NSE and S100B: A supplemental tool for detecting a lethal traumatic brain injury?

Sieber M, Dreßler J, Franke H, Pohlers D, Ondruschka B.

J Forensic Leg Med. 2018 Apr;55:65-73. doi: 10.1016/j.jflm.2018.02.016. Epub 2018 Feb 14.

PMID:
29471249
16.

Reliability of calcium-binding protein S100B measurement toward optimization of hyperosmolal therapy in traumatic brain injury.

Hendoui N, Beigmohammadi MT, Mahmoodpoor A, Ahmadi A, Abdollahi M, Hasanpour M, Hadi F, Khazaeipour Z, Mousavi S, Mojtahedzadeh M.

Eur Rev Med Pharmacol Sci. 2013 Feb;17(4):477-85.

17.

Diagnostic value of S100B and neuron-specific enolase in mild pediatric traumatic brain injury.

Geyer C, Ulrich A, Gräfe G, Stach B, Till H.

J Neurosurg Pediatr. 2009 Oct;4(4):339-44. doi: 10.3171/2009.5.PEDS08481.

PMID:
19795965
18.

Secondary peaks of S100B in serum relate to subsequent radiological pathology in traumatic brain injury.

Thelin EP, Nelson DW, Bellander BM.

Neurocrit Care. 2014 Apr;20(2):217-29. doi: 10.1007/s12028-013-9916-0.

PMID:
24146416
19.

Serum neurofilament light protein predicts clinical outcome in traumatic brain injury.

Shahim P, Gren M, Liman V, Andreasson U, Norgren N, Tegner Y, Mattsson N, Andreasen N, Öst M, Zetterberg H, Nellgård B, Blennow K.

Sci Rep. 2016 Nov 7;6:36791. doi: 10.1038/srep36791.

20.

S100B serum level predicts computed tomography findings after minor head injury.

Müller K, Townend W, Biasca N, Undén J, Waterloo K, Romner B, Ingebrigtsen T.

J Trauma. 2007 Jun;62(6):1452-6.

PMID:
17563665

Supplemental Content

Support Center